Explore All 542 Buyout (LBO, MBO, MBI) Medical Products Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | January 23, 2008 |
| Target | Signature Genomic Laboratories |
| Sector | Medical Products |
| Buyer(s) | Ampersand Capital Partners |
| Deal Type | Buyout (LBO, MBO, MBI) |
FILTER BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1988 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.
| Deal Context for Buyer | # |
|---|---|
| Overall | 17 of 86 |
| Sector: Medical Products | 5 of 18 |
| Type: Buyout (LBO, MBO, MBI) | 6 of 23 |
| State: Washington | 1 of 1 |
| Country: United States | 17 of 70 |
| Year: 2008 | 2 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-01-05 |
K-TEK
Prairieville, Louisiana, United States K-TEK Corp. is a manufacturer, and supplies level instrumentation for liquid and bulk solids detection in North America. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-08-12 |
Talecris Biotherapeutics Holdings Corp
Research Triangle Park, North Carolina, United States Talecris Biotherapeutics Holdings Corp. is a pharmaceutical Development and Manufacturing company. |
Sell | $3.1B |
